Device Trial Radar · NCT03622866
Algovita Spinal Cord Stimulation System Hi-Fi Study
Last checked: Nov 19, 2026Latest source record: Mar 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
20
Actual
Start
Nov 2, 2018
Primary completion
Apr 27, 2020
Study completion Apr 27, 2020
Sponsor
- Lead sponsor
- NuvectraNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Bright Research Partners
- First posted
- Aug 9, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to obtain post-market clinical outcome data for the Algovita SCS System when used on-label, according to the applicable directions for use, using high fidelity tonic stimulation at either ultra-high pulse width or traditional pulse width for the treatment of persistent or recurrent back and/or leg pain following spinal surgery.
Conditions
- Chronic Pain
Interventions
Ultra-high pulse width stimulationDevice
Algovita Spinal Cord Stimulation System with associated components
Traditional pulse width stimulationDevice
Algovita Spinal Cord Stimulation System with associated components
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effectiveness of targeted pain reduction compared to baseline in each treatment armTime frame: Week 25
- Rate of serious study-related adverse events (AEs) in each treatment armTime frame: From Permanent Implant through Week 25
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Pain Institute of Southern Arizona
Tucson, Arizona
Newport Beach Headache & Pain
Newport Beach, California
Summit Pain Alliance
Santa Rosa, California
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.